I believe that this information will be of great news to many. Check this out:
MMRF CoMMunity Gateway Myeloma Expert Post: Read a
post from Dr. Craig Hofmeister from The Ohio State University about
"A Study to Evaluate 3 Dose Schedules of Daratumumab in
Participants With Smoldering Multiple Myeloma."